🇦🇪 Cedilanid D in United Arab Emirates

Cedilanid D (DESLANOSIDE) regulatory status in United Arab Emirates.

Marketing authorisation

MOH

  • Status: likely_approved

Cedilanid D in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in United Arab Emirates

Frequently asked questions

Is Cedilanid D approved in United Arab Emirates?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Cedilanid D in United Arab Emirates?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.